2.

各种影响因素与阿瑞匹坦止吐疗效的关系

The relationship between the effect factors and the efficacy of Aprepitant

Item	CR (0-120 h)	Invalid (0-120 h)	CP (0-120 h)	χ2	P
Tumor				1.328	0.515
Lung cancer	63 (61.2%)	6 (5.8%)	34 (33.0%)
Gastrointestinal	20 (52.6%)	4 (10.5%)	14 (36.8%)
Age (yr)				12.584	0.008
< 65	56 (65.9%)	2 (2.4%)	27 (31.8%)
65-75	20 (52.6%)	5 (13.2%)	13 (34.2%)
> 75	6 (46.2%)	4 (30.8%)	3 (23.1%)
Gender				2.725	0.256
Male	61 (60.4%)	6 (5.9%)	34 (33.7%)
Female	22 (61.1%)	5 (13.9%)	9 (25.0%)
ECOG PS score				2.467	0.291
0	64 (62.7%)	7 (6.9%)	31 (30.4%)
1	17 (53.1%)	5 (15.6%)	10 (31.2%)